Hypericin can cross barriers in the chicken's chorioallantoic membrane model when delivered in low-density lipoproteins

被引:14
作者
Blascakova, Ludmila [1 ,2 ]
Horvath, Denis [2 ]
Belej, Dominik [1 ]
Wagnieres, Georges [3 ]
Miskovsky, Pavol [2 ,4 ]
Jancura, Daniel [1 ,2 ]
Huntosova, Veronika [2 ]
机构
[1] PJ Safarik Univ Kosice, Fac Sci, Dept Biophys, Jesenna 5, Kosice 04154, Slovakia
[2] PJ Safarik Univ Kosice, Ctr Interdisciplinary Biosci, Technol & Innovat Pk,Jesenna 5, Kosice 04154, Slovakia
[3] Swiss Fed Inst Technol Lausanne EPFL, Inst Phys, Lab Funct & Metab Imaging, Stn 6,Batiment Chim, CH-1015 Lausanne, Switzerland
[4] SAFTRA Photon Ltd, Jesenna 5, Kosice 04154, Slovakia
基金
瑞士国家科学基金会;
关键词
Lipoproteins; Biodistribution; In ovo; Hypericin; Bootstrapping and bagging; PHOTODYNAMIC THERAPY; PHOTOSENSITIZER HYPERICIN; CANCER; CELLS; RECEPTOR; LUMINESCENCE; AGGREGATION; MECHANISMS; PRINCIPLES; DYNAMICS;
D O I
10.1016/j.pdpdt.2018.07.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Low-density lipoproteins (LDL) were used as a natural drug delivery system for the transport of hypericin (Hyp) in the bloodstream of the chicken's chorioallantoic membrane model (CAM). Hyp was chosen as a model for hydrophobic drug used in photo-diagnosis and photo-treatments (PDT). The extravasation of the Hyp:LDL complexes for different concentration ratios and the redistribution of Hyp between different serum components were investigated with an innovative statistical treatment. Methods: Hyp biodistribution was monitored in CAM by intravital fluorescence microscopy. The innovative statistical treatment of experimental data presented here enabled us to obtain highly detailed information from the weak Hyp fluorescence distribution in CAM blood vessels. Hyp redistribution between the serum components was studied by fluorescence spectroscopy in lipids/protein composed solutions. Results: Extravasation of Hyp was dependent on Hyp:LDL concentration ratio. While Hyp:LDL = 50:1 resulted in a significant Hyp extravasation, the Hyp extravasation from Hyp:LDL = 100:1 was weak. The redistribution of Hyp was found to be faster for lipidic particles than for proteins. Conclusion: We have demonstrated that lipids composition has a significant control over Hyp delivery in CAM.
引用
收藏
页码:306 / 313
页数:8
相关论文
共 43 条
[31]   Accumulation and interaction of hypericin in low-density lipoprotein - A photophysical study [J].
Mukheriee, Prasun ;
Adhikary, Ramkrishna ;
Halder, Mintu ;
Petrich, Jacob W. ;
Miskovsky, Pavol .
PHOTOCHEMISTRY AND PHOTOBIOLOGY, 2008, 84 (03) :706-712
[32]   The chicken chorioallantoic membrane model in biology, medicine and bioengineering [J].
Nowak-Sliwinska, Patrycja ;
Segura, Tatiana ;
Iruela-Arispe, M. Luisa .
ANGIOGENESIS, 2014, 17 (04) :779-804
[33]   New Frontier in Hypericin-Mediated Diagnosis of Cancer with Current Optical Technologies [J].
Olivo, Malini ;
Fu, Chit Yaw ;
Raghavan, Vijaya ;
Lau, Weber Kam On .
ANNALS OF BIOMEDICAL ENGINEERING, 2012, 40 (02) :460-473
[34]   Targeted photodynamic therapy via receptor mediated delivery systems [J].
Sharman, WM ;
van Lier, JE ;
Allen, CM .
ADVANCED DRUG DELIVERY REVIEWS, 2004, 56 (01) :53-76
[35]   Principles in the design of ligand-targeted cancer therapeutics and imaging agents [J].
Srinivasarao, Madduri ;
Galliford, Chris V. ;
Low, Philip S. .
NATURE REVIEWS DRUG DISCOVERY, 2015, 14 (03) :203-219
[36]   Light-induced retinal vascular damage by Pd-porphyrin luminescent oxygen probes [J].
Stepinac, TK ;
Chamot, SK ;
Rungger-Brändle, E ;
Ferrez, P ;
Munoz, JL ;
van den Bergh, H ;
Riva, CE ;
Pournaras, CJ ;
Wagnières, GA .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46 (03) :956-966
[37]   Toward a magic or imaginary bullet? Ligands for drug targeting to cancer cells: principles, hopes, and challenges [J].
Toporkiewicz, Monika ;
Meissner, Justyna ;
Matusewicz, Lucyna ;
Czogalla, Aleksander ;
Sikorski, Aleksander F. .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2015, 10 :1399-1414
[38]   Elucidation of the tumoritropic principle of hypericin [J].
Van de Putte, M ;
Roskams, T ;
Vandenheede, JR ;
Agostinis, P ;
de Witte, PAM .
BRITISH JOURNAL OF CANCER, 2005, 92 (08) :1406-1413
[39]  
Veaux R. D., 2005, BAGGING BOOSTING ENC
[40]   Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications [J].
Wicki, Andreas ;
Witzigmann, Dominik ;
Balasubramanian, Vimalkumar ;
Huwyler, Joerg .
JOURNAL OF CONTROLLED RELEASE, 2015, 200 :138-157